Research To Practice | Oncology Videos

Latest Episodes:

Hematologic Cancers | Data + Perspectives: Investigators Discuss the Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies in the Care of Patients with Hematologic Cancers Sep 01, 2022

Show notes

Featuring perspectives from Drs Ajai Chari, Ian Flinn, Nikhil Munshi and Laurie Sehn, including the following topics:

Part 1: Case Presentations and Clinical Decision-Making (0:00)
Case: A man in his early 70s with diffuse large B-cell lymphoma (DLBCL) arising from follicular lymphoma — Ian W Flinn, MD, PhD (3:46)
Case: A man in his late 50s with nongerminal center B-cell-like subtype DLBCL — Laurie H Sehn, MD, MPH (15:57)
Case: CAR-T therapy during the pandemic — Nikhil C Munshi, MD (22:16)
Case: Anti-BCMC bispecific in triple-class and penta-drug refractory disease — Ajai Chari, MD (33:54)
CAR-T therapy for non-Hodgkin lymphoma — Dr Flinn (37:09)
Bispecifics for non-Hodgkin lymphoma — Dr Sehn (51:48)
CAR-T therapy for multiple myeloma — Dr Munshi (1:13:23)
Bispecifics for multiple myeloma — Dr Chari (1:26:14)

CME information and select publications

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 Aug 31, 2022

Show notes

Featuring perspectives from Prof Jonathan Ledermann, including the following topics:

Introduction (0:00)
Case: An Asian woman in her early 80s with ovarian cancer and a gBRCA mutation receiving maintenance olaparib after surgery and adjuvant chemotherapy — Rao Mushtaq, MD (2:05)
Journal Club with Prof Ledermann (7:58)
Case: A woman in her mid 80s with gBRCA wild-type high-grade serous ovarian cancer (HGSOC) who develops recurrent disease after declining maintenance niraparib — Priya Rudolph, MD, PhD (17:28)
Antibody-Drug Conjugates for Ovarian Cancer (23:09)
Case: A woman in her mid 70s with HGSOC and gBRCA1 and 2 mutations who responds to olaparib for 5 years but then develops progressive disease after stopping — Karim ElSahwi, MD (33:38)
Case: A woman in her late 60s with gBRCA wild-type Stage IIIC ovarian cancer who receives IV/IP adjuvant chemotherapy — Gigi Chen, MD (43:19)
Case: A woman in her mid 40s with microsatellite instability-high BRCA wild-type clear cell ovarian cancer with stable disease on pembrolizumab — Syed F Zafar, MD (47:59)
Case: A woman in her late 50s with recurrent BRCA wild-type (HRp) low-grade ovarian cancer with rising CA-125, pleural effusion and a new lung nodule on salvage chemotherapy — Dana M Chase, MD (52:48)
Case: A woman in her early 90s with past medical history of untreated chronic lymphocytic leukemia who presents with Stage III/IV ovarian cancer — Rajalaxmi McKenna, MD (56:45)

CME information and select publications

Lung Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network Aug 25, 2022

Show notes

Proceedings from a daylong multitumor educational symposium in partnership with the American Oncology Network, featuring perspectives from Drs Ibiayi Dagogo-Jack and Suresh Ramalingam on recent advances and real-world implications in lung cancer.

CME information and select publications

Chronic Lymphocytic Leukemia and Lymphomas | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network Aug 25, 2022

Show notes

Proceedings from a daylong multitumor educational symposium in partnership with the American Oncology Network, featuring perspectives from Drs Brad S Kahl and Craig Moskowitz on recent advances and real-world implications in chronic lymphocytic leukemia and lymphomas.

CME information and select publications

Multiple Myeloma | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network Aug 25, 2022

Show notes

Proceedings from a daylong multitumor educational symposium in partnership with the American Oncology Network, featuring perspectives from Drs Rafael Fonseca and Krina Patel on recent advances and real-world implications in multiple myeloma.

CME information and select publications

Genitourinary Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network Aug 25, 2022

Show notes

Proceedings from a daylong multitumor educational symposium in partnership with the American Oncology Network, featuring perspectives from Drs Neeraj Agarwal and Sandy Srinivas on recent advances and real-world implications in genitourinary cancers.

CME information and select publications

Breast Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network Aug 25, 2022

Show notes

Proceedings from a daylong multitumor educational symposium in partnership with the American Oncology Network, featuring perspectives from Drs Harold Burstein and Joyce O'Shaughnessy on recent advances and real-world implications in breast cancer.

CME information and select publications

Lung Cancer | Oncology Today with Dr Neil Love: Key Presentations in Lung Cancer from the 2022 ASCO Annual Meeting (Companion Faculty Lecture) Aug 24, 2022

Show notes

Featuring a slide presentation and related discussion from Dr Joshua Sabari, including the following topics:

Recent updates from ASCO 2022 in the use of EGFR- and MET-targeted therapies (0:00)
Targeting HER3 in patients with advanced non-small cell lung cancer (NSCLC) with and without EGFR mutations (16:04)
Recent updates in therapy for patients with EGFR exon 20 insertion mutations (21:47)
DESTINY-Lung04 trial: Trastuzumab deruxtecan for patients with HER2 exon 19 or 20 mutations (2921)
Using mutational status in predicting patient benefit from chemoimmunotherapy (34:51)
Immune checkpoint inhibition for patients with NSCLC with EGFR mutations (38:41)
Combining novel agents with immune checkpoint inhibitors for patients with NSCLC and high PD-L1 expression (47:36)

CME information and select publications

Lung Cancer | Oncology Today with Dr Neil Love: Key Presentations in Lung Cancer from the 2022 ASCO Annual Meeting Aug 24, 2022

Show notes

Featuring an interview with Dr Joshua Sabari, including the following topics:

Updates in the use of adjuvant targeted therapy for localized and metastatic non-small cell lung cancer (NSCLC); impact of the ADAURA trial (0:00)
Factors in the selection of second-line therapy for patients with and without driver mutations (10:30)
Role of immunotherapy for patients with driver mutations (14:26)
Recent updates in the use of antibody-drug conjugates for NSCLC (17:01)
Combining VEGF inhibition with other therapies for previously treated NSCLC (20:10)
Factors affecting response to immunotherapy in patients with lung cancer (23:19)

CME information and select publications

Gastrointestinal Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network Aug 18, 2022

Show notes

Proceedings from a daylong multitumor educational symposium in partnership with the American Oncology Network, featuring perspectives from Drs Rutika Mehta and Philip Philip on recent advances and real-world implications in gastrointestinal cancers.

CME information and select publications